Two-in-One Nanoparticle Formulation to Deliver a Tyrosine Kinase Inhibitor and microRNA for Targeting Metabolic Reprogramming and Mitochondrial Dysfunction in Gastric Cancer.

Pharmaceutics · 2022 · PMC9504622 · PMID 36145507

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp < 0.001actually significant

A highly significant amplification in fluorescence intensity was found in cells treated with FAM-miR-125 + Afa/SLN-KL compared with that in cells treated with FAM-miR-125 ( p < 0.001; Figure 2 B, left).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.